SAPHNELO Supports Co-pay Savings Program
OpenVerified·Mar 20, 2026
- Covers
- financial assistance
- Enrollment cycle
- rolling
Eligibility
Eligible patients must be adults with moderate to severe systemic lupus erythematosus who are currently receiving other lupus medications. The co-pay program is intended for individuals with commercial insurance, while the AZ&Me program provides additional support for those who meet separate eligibility criteria.
Status source
SIGN UP TO RECEIVE YOUR WELCOME KIT!